Firm that develops replacement organs raises $50 million

06/27/2006 | Philadelphia Inquirer, The

Replacement organ developer Tengion has raised $50 million in private equity, which it plans to use for clinical trials of its lead product, a bladder for patients with spina bifida and spinal-cord injuries. The funds also will be used to advance the company's product pipeline and create a 45,000-square-foot manufacturing facility.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC